Advertisement
Screener

GREENLAND MINES LTD (GRML) Operating Income

GREENLAND MINES LTD Operating Income

GREENLAND MINES LTD (GRML) reported Operating Income of -$5.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-17

  • GREENLAND MINES LTD operating income (loss) for the quarter ending 2026-06-30 was -$5.49M.
  • GREENLAND MINES LTD operating income (loss) for the quarter ending 2026-03-31 was -$9.51M.
  • GREENLAND MINES LTD operating income (loss) for the quarter ending 2025-12-31 was -$1.81M.
  • GREENLAND MINES LTD operating income (loss) for the quarter ending 2025-09-30 was -$1.85M.
  • GREENLAND MINES LTD operating income (loss) for fiscal 2025 was -$7.15M.
  • GREENLAND MINES LTD operating income (loss) for fiscal 2024 was -$5.54M.
  • GREENLAND MINES LTD operating income (loss) for fiscal 2023 was -$631.32K.
  • GREENLAND MINES LTD operating income (loss) for fiscal 2022 was -$657.02K.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 7 monthOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 10 monthOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30-$5.49M
10-Q · filed 2026-08-17
-$15.00M
10-Q · filed 2026-08-17
-$16.82M
derived: sum of 3 quarters · filed 2026-08-17
-$18.67M
derived: sum of 4 quarters · filed 2026-08-17
2026-03-31-$9.51M
10-Q/A · filed 2026-08-14
-$11.33M
derived: sum of 2 quarters · filed 2026-08-14
-$13.18M
derived: sum of 3 quarters · filed 2026-08-14
-$15.07M
derived: sum of 4 quarters · filed 2026-08-17
2025-12-31-$1.81M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14
-$3.67M
derived: sum of 2 quarters · filed 2026-08-14
-$5.56M
derived: sum of 3 quarters · filed 2026-08-17
-$7.15M
10-K/A · filed 2026-08-14
2025-09-30-$1.85M
10-Q · filed 2025-11-13
-$3.75M
derived: sum of 2 quarters · filed 2026-08-17
-$5.33M
10-Q · filed 2025-11-13
-$7.18M
derived: sum of 4 quarters · filed 2026-08-17
2025-06-30-$1.89M
10-Q · filed 2026-08-17
-$3.48M
10-Q · filed 2026-08-17
-$5.33M
derived: sum of 3 quarters · filed 2026-08-17
-$8.20M
derived: sum of 4 quarters · filed 2026-08-17
2025-03-31-$1.59M
10-Q/A · filed 2026-08-14
-$3.44M
derived: sum of 2 quarters · filed 2026-08-14
-$6.31M
derived: sum of 3 quarters · filed 2026-08-14
-$6.71M
derived: sum of 4 quarters · filed 2026-08-14
2024-12-31-$1.85M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14
-$4.72M
derived: sum of 2 quarters · filed 2026-08-14
-$5.12M
derived: sum of 3 quarters · filed 2026-08-14
-$5.54M
10-K/A · filed 2026-08-14
2024-09-30-$2.87M
10-Q · filed 2025-11-13
-$3.27M
derived: sum of 2 quarters · filed 2025-11-13
-$3.69M
10-Q · filed 2025-11-13
-$4.05M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$395.61K
10-Q · filed 2025-08-18
-$817.65K
10-Q · filed 2025-08-18
-$1.18M
derived: sum of 3 quarters · filed 2025-08-18
-$1.30M
derived: sum of 4 quarters · filed 2025-08-18
2024-03-31-$672.04K
10-Q · filed 2025-05-15
-$342.78K
10-Q · filed 2024-05-23
-$782.78K
derived: sum of 2 quarters · filed 2025-05-15
-$906.51K
derived: sum of 3 quarters · filed 2025-05-15
-$1.15M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$110.73K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$234.47K
derived: sum of 2 quarters · filed 2025-03-31
-$478.72K
derived: sum of 3 quarters · filed 2025-03-31
-$631.32K
10-K · filed 2025-03-31
-$1.30M
10-K · filed 2024-04-17
2023-09-30-$123.74K
10-Q · filed 2024-11-19
-$292.23K
10-Q · filed 2023-11-17
-$367.99K
derived: sum of 2 quarters · filed 2024-11-19
-$520.59K
10-Q · filed 2024-11-19
-$975.93K
10-Q · filed 2023-11-17
-$933.29K
derived: sum of 4 quarters · filed 2024-11-19
2023-06-30-$244.25K
10-Q · filed 2024-08-19
-$357.95K
10-Q · filed 2023-08-21
-$396.85K
10-Q · filed 2024-08-19
-$683.71K
10-Q · filed 2023-08-21
-$809.55K
derived: sum of 3 quarters · filed 2024-08-19
-$989.27K
derived: sum of 4 quarters · filed 2024-08-19
2023-03-31-$325.75K
10-Q · filed 2024-05-23
-$565.30K
derived: sum of 2 quarters · filed 2024-05-23
-$745.02K
derived: sum of 3 quarters · filed 2024-05-23
-$977.76K
derived: sum of 4 quarters · filed 2024-05-23
2022-12-31-$239.54K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17
-$419.27K
derived: sum of 2 quarters · filed 2024-04-17
-$652.01K
derived: sum of 3 quarters · filed 2024-04-17
-$657.02K
10-K · filed 2024-04-17
2022-09-30-$179.73K
10-Q · filed 2023-11-17
-$412.47K
derived: sum of 2 quarters · filed 2023-11-17
-$417.48K
10-Q · filed 2023-11-17
2022-06-30-$232.74K
10-Q · filed 2023-08-21
-$237.75K
10-Q · filed 2023-08-21
2022-03-31-$5.01K
10-Q · filed 2023-05-24
2021-12-31-$3.56K
10-K/A · filed 2023-10-18
2021-09-30-$16.00
10-Q · filed 2022-11-14
-$3.53K
10-Q · filed 2022-11-14
2021-06-30-$3.51K
10-Q · filed 2022-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43